Libo Wang is a graduate of Xinxiang Medical University in China and is doing his PhD in Henan normal University in 2020. Dr.Wang’s research mainly focuses on elucidating the roles of Chinese traditional medicine in the treatment of cardiovascular diseases or pulmonary fibrosis. His studies have employed a wide range of techniques from molecular and cell biology, as well as in vivo physiology, to investigate mechanisms underlying the adaptive and maladaptive changes during the development of various cardiovascular diseases. His main findings have been published in journals including in JACC BTS, Frontiers in pharmacology, Journal of Materials Chemistry B, BMC Cardiovasc Disord, Epigenomics etc.